Mabpharm Limited (02181.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 9Sep 14Sep 18

Key dataSep 18, 2026

OpenHKD 0.41

From 52W high−51.25%

Volume118000.00

Market capHKD 1.61B

P/E (TTM)16.3x

P/S (TTM)1.8x

Div yield—

Key dataSep 18, 2026

Open

HKD 0.41

From 52W high

−51.25%

Volume

118000.00

Market cap

HKD 1.61B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.6x

P/E (TTM)

16.3x

RSI (14)

33.7

MomentumView details →

1D Return

−7.14%

YTD Return

−22.00%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

16.3x

EV/EBITDA

16.6x

EV/Sales

2.1x

P/S (TTM)

1.8x

P/B (TTM)

7.1x

ProfitabilityView details →

Gross Margin

85.42%

Net Margin

11.09%

EBITDA Margin

12.56%

ROE (TTM)

43.72%

ROA (TTM)

7.25%

Asset Turnover

0.66x

GrowthView details →

Revenue YoY

+80.24%

EPS YoY

+405.97%

FCF YoY

−66.75%

Revenue CAGR 3Y

+124.11%

EPS CAGR 3Y

+143.55%

EBITDA YoY

+234.20%

MomentumView details →

1D Return

−7.14%

YTD Return

−22.00%

1Y Return

−50.00%

RSI (14)

33.7

vs 50D SMA

−7.45%

vs 200D SMA

−16.67%

Capital & dividendView details →

Debt/Equity

1.59x

Current Ratio

0.83x

Quick Ratio

0.54x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.19B

Net Income (TTM)

57.24M

Op. CF (TTM)

202.60M

Next earningsMar 31, 2027 →

Latest newsMore news →

No recent news for 02181.HK.

Similar companies

Inhibrx Biosciences, Inc.INBX Eton Pharmaceuticals, Inc.ETON AnaptysBio, Inc.ANAB Forte Biosciences, Inc.FBRX Taysha Gene Therapies, Inc.TSHA Syndax Pharmaceuticals, Inc.SNDX Find similar companies →

Latest newsMore news →

No recent news for 02181.HK.